Clinical trial on the effect of Azyter in patients with blepharitis.

Completed

• Conditions: Blepharitis

• Registration Number: NL-OMON20089

Brief Summary

Opitz DL, Tyler KF. Efficacy of azithromycin 1% ophthalmic solution for treatment of ocular surface disease from posterior blepharitis. Clin Exp Optom. 2011 Mar;94(2):200-6.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

1. Symptoms of blepharitis;

2. HLA-DR > 15% on conjunctival cells;

Exclusion Criteria

1. Glaucoma;

2. Ocular surface infections;

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluation of HLA-DR expression levels after treatment with Azyter.

Secondary Outcome Measures

Name	Time	Method
Symptoms and signs of blepharitis, and level of cytokines in tears after treatment with Azyter.